Gefitinib (Iressa)
Important Notice: For research use only. We do not sell to patients.
Other Forms of Gefitinib (Iressa)
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Gefitinib is an EGFR inhibitor, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. | ||
---|---|---|---|
Targets |
|
Catalog Num | A10422 |
---|---|
Formula | C22H24ClFN4O3 |
Molecular Weight | 446.9 |
CAS Number | 184475-35-2 |
SMILES | COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4 |
Synonyms | ZD-1839 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 80 mg/mL (179 mM) | |
Water | Insoluble | ||
Ethanol | 4 mg/mL (8.95 mM) | ||
In vivo | 1% CMC Na | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.38 mL | 111.88 mL | 223.76 mL |
0.5 mM | 4.48 mL | 22.38 mL | 44.75 mL |
1 mM | 2.24 mL | 11.19 mL | 22.38 mL |
5 mM | 0.45 mL | 2.24 mL | 4.48 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2